These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25528336)

  • 1. Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II).
    Ettaoussi M; Pérès B; Errazani A; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2015 Jan; 90():822-33. PubMed ID: 25528336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of a series of the agomelatine analogues as melatonin MT1 /MT2 agonist and 5-HT2C antagonist.
    Ettaoussi M; Sabaouni A; Pérès B; Landagaray E; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
    ChemMedChem; 2013 Nov; 8(11):1830-45. PubMed ID: 24031039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).
    Ettaoussi M; Sabaouni A; Rami M; Boutin JA; Delagrange P; Renard P; Spedding M; Caignard DH; Berthelot P; Yous S
    Eur J Med Chem; 2012 Mar; 49():310-23. PubMed ID: 22301214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT
    Duroux R; Rami M; Landagaray E; Ettaoussi M; Caignard DH; Delagrange P; Melnyk P; Yous S
    Eur J Med Chem; 2017 Dec; 141():552-566. PubMed ID: 29102176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers.
    Kamal M; Gbahou F; Guillaume JL; Daulat AM; Benleulmi-Chaachoua A; Luka M; Chen P; Kalbasi Anaraki D; Baroncini M; Mannoury la Cour C; Millan MJ; Prevot V; Delagrange P; Jockers R
    J Biol Chem; 2015 May; 290(18):11537-46. PubMed ID: 25770211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.
    Bolteau R; Descamps F; Ettaoussi M; Caignard DH; Delagrange P; Melnyk P; Yous S
    Eur J Med Chem; 2020 Mar; 189():112078. PubMed ID: 32004937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
    Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
    Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands.
    Rami M; Landagaray E; Ettaoussi M; Boukhalfa K; Caignard DH; Delagrange P; Berthelot P; Yous S
    Molecules; 2012 Dec; 18(1):154-66. PubMed ID: 23262445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
    Hu Y; Chan KH; He X; Ho MK; Wong YH
    PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
    Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
    Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
    Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agomelatine but not melatonin improves fatigue perception: a longitudinal proof-of-concept study.
    Pardini M; Cordano C; Benassi F; Mattei C; Sassos D; Guida S; Serrati C; Primavera A; Amore M; Cocito L; Emberti Gialloreti L
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):939-44. PubMed ID: 24636462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new melatoninergic hexahydroindenopyridines.
    Moreno L; Berenguer I; Diaz A; Marín P; Párraga J; Caignard DH; Figadère B; Cabedo N; Cortes D
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3534-6. PubMed ID: 24930835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
    Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
    Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of ligand recognition at the human MT
    Stauch B; Johansson LC; McCorvy JD; Patel N; Han GW; Huang XP; Gati C; Batyuk A; Slocum ST; Ishchenko A; Brehm W; White TA; Michaelian N; Madsen C; Zhu L; Grant TD; Grandner JM; Shiriaeva A; Olsen RHJ; Tribo AR; Yous S; Stevens RC; Weierstall U; Katritch V; Roth BL; Liu W; Cherezov V
    Nature; 2019 May; 569(7755):284-288. PubMed ID: 31019306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evidence for transactivation within melatonin MT
    Gerbier R; Ndiaye-Lobry D; Martinez de Morentin PB; Cecon E; Heisler LK; Delagrange P; Gbahou F; Jockers R
    FASEB J; 2021 Jan; 35(1):e21161. PubMed ID: 33156577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
    Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
    J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
    Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
    Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.